Facebook
Twitter
Telegram
Report an ErrorAdial Pharmaceuticals Financial Statements 2011-2024 | ADIL
Annual Financial Statements Adial Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.05 M | 406 K | 50.2 M | 21.2 M | 15.7 M | 26.1 M | - | - | - | - | - | - | - |
Shares |
1.66 M | 1.07 M | 18.6 M | 9.85 M | 9.85 M | 4.76 M | - | - | - | - | - | - | - |
Historical Prices |
1.23 | 0.38 | 2.7 | 1.7 | 2.41 | 5.12 | - | - | - | - | - | - | - |
Net Income |
-5.12 M | -12.7 M | -19.4 M | -10.9 M | -8.59 M | -11.6 M | -1.14 M | -420 K | -818 K | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-6.89 M | -10.9 M | -19.3 M | -10.9 M | -8.24 M | -6.99 M | -995 K | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-6.89 M | -10.9 M | -19.3 M | -10.9 M | -8.24 M | -6.99 M | -994 K | -410 K | -817 K | - | - | - | - |
Operating Expenses |
6.89 M | 10.9 M | 19.3 M | - | 8.24 M | 6.99 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.62 M | 8.91 M | 9.34 M | 5.07 M | 4.28 M | 6.62 M | 813 K | 265 K | 497 K | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Adial Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
1.22 M | 1.2 M | 26.5 M | 1.07 M | 25.7 M | 24.3 M | 23.2 M | 20.9 M | 19.8 M | 17.6 M | 15.9 M | 14.4 M | 13.6 M | 11.3 M | 10.5 M | 10.4 M | 10.3 M | 10.2 M | 8.25 M | 6.86 M | 5.55 M | 3.56 M | 3.27 M | 3.27 M | 3.27 M | 3.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.38 M | 1.09 M | -2.91 M | - | -3.11 M | -3.85 M | -2.91 M | - | -4.32 M | -4.44 M | -4.83 M | - | -3.34 M | -1.81 M | -2.28 M | - | -1.72 M | -2.13 M | -2.68 M | - | -8.19 M | -1.79 M | -379 K | - | -1.14 M | -1.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | 99.2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-1.36 M | -1.48 M | -2.92 M | - | -3.19 M | -3.83 M | -3.06 M | - | -4.06 M | -4.4 M | -4.84 M | - | -3.34 M | -1.82 M | -2.3 M | - | -1.75 M | -2.16 M | -2.25 M | - | -3.82 M | -1.74 M | -340 K | - | -262 K | -241 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.9 K | - | - | - | 22.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -2.92 M | - | -3.19 M | -3.83 M | -3.06 M | - | -4.06 M | -4.4 M | -4.84 M | - | -3.34 M | -1.82 M | -2.3 M | - | -1.75 M | -2.16 M | -2.25 M | - | -3.82 M | -1.74 M | -339 K | - | -262 K | -241 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
1.36 M | 1.48 M | 2.92 M | - | 3.19 M | 3.83 M | 3.06 M | - | 4.06 M | 4.4 M | 4.84 M | - | 3.34 M | 1.82 M | 2.3 M | - | 1.75 M | 2.16 M | 2.25 M | - | 3.82 M | 1.74 M | 340 K | - | 262 K | 241 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.15 M | 1.05 M | 2.24 M | - | - | - | 2.46 M | - | 2.37 M | 2.08 M | 2.79 M | - | 1.49 M | 931 K | 1.24 M | - | 881 K | 949 K | 1.56 M | - | 3.63 M | 1.66 M | 284 K | - | 161 K | 161 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency